UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: Relationships to serum bilirubin concentrations

Pharmacogenetics

Volumn 9, Issue 3, 1999, Pages 341-349

  Lampe, Johanna W ^a   Bigler, Jeannette ^a   Horner, Neilann K ^a   Potter, John D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Genotype; Glucuronosyltransferases; Serum bilirubin; UGT1A1 gene promoter; UGT1A6

Indexed keywords

4 HYDROXYCOUMARIN; 4 NITROPHENOL; BILIRUBIN; GLUCURONOSYLTRANSFERASE; GUAIACOL;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; BILIRUBIN BINDING; BILIRUBIN BLOOD LEVEL; BILIRUBIN METABOLISM; CAUCASIAN; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; HUMAN; MALE; MISSENSE MUTATION; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032767352     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199906000-00009     Document Type: Article

References (28)

1. Adachi Y, Yamashita M, Nanno T, Yamamoto T. Proportion of conjugated bilirubin in bile in relation to hepatic bilirubin UDP-glucuronyltransferase activity. Clin Biochem 1990; 23:131-134.
2. Ando Y, Chida M, Nakayama K, Saka H, Kamataki T. The UGT1A1*28 allele is relatively rare in a Japanese population. Pharmacogenetics 1998; 8:357-360.
3. Appelt LC, Reicks MM. Soy feeding induces phase II enzymes in rat tissues. Nutr Cancer 1997; 28:270-275.
4. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci 1998; 95:8170-8174.
5. Bock KW. UDP-glucuronosyltransferases and their role in metabolism and disposition of carcinogens. Adv Pharmacol 1994; 27:367-383.
6. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer N, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995; 333:1171-1175.
7. Burchell B, Ebner T, Baird S, Senafi SB, Clarke D, Brierley C, Sutherland L. Use of cloned and expressed human liver UDP-glucuronosyltransferases for analysis of drug glucuronide formation and assessment of drug toxicity. Environ Health Perspect 1994; 102 (Suppl. 9):19-23.
8. Ciotti M, Marrone A, Potter C, Owens IS. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 1997; 7:485-495.
9. Fischer AF, Nakamura H, Uetani Y, Vreman HJ, Stevenson DK. Comparison of bilirubin production in Japanese and Caucasian infants. J Pediatr Gastroenterol Nutr 1988; 7:27-29.
10. Harding D, Fournel-Gigleux S, Jackson MR, Burchell B. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc Natl Acad Sci 1988; 85:8381-8385.
11. Horiguchi T, Bauer C. Ethnic differences in neonatal jaundice: comparison of Japanese and Caucasian newborn infants. Am J Obstet Gynecol 1975; 121:71-74.
12. Hu Z, Wells PG. In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. J Pharmacol Exp Ther 1992; 263:334-342.
13. Mackenzie PI, Mojarrabi B, Meech R, Hansen A. Steroid UDP glucuronosyltransferases: characterization and regulation. J Endocrinol 1996; 150, S79-S86.
14. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Bélanger A, et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update bused on evolutionary divergence. Pharmacogenetics 1997; 7:255-269.
15. Malloy HT, Evelyn KA. The determination of bilirubin with the photoelectric colorimeter. J Biol Chem 1937; 119:481-490.
16. Mirsalis JC, Hamilton CM, Schindler JE, Green CE, Dabbs JE. Effects of soya flakes and liquorice root extract on enzyme induction and toxicity on B6C3F1 mice. Food Chem Toxicol 1993; 31:343-350.
17. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996; 347:578-581.
18. Monaghan G, Foster B, Jurima-Romet M, Hume R, Burchell B. UGT1*1 genotyping in a Canadian Inuit population. Pharmacogenetics 1997; 7:153-156.
19. Muraca M, Fevery J, Blanckaert N. Analytic aspects and clinical interpretation of serum bilirubins. Sem Liver Dis 1988; 8:137-147.
20. Nickerson DA, Kaiser R, Lappin S, Stewart J, Hood L, Landegren U. Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci USA 1990; 87:8923-8927.
21. Orzechowski A, Schrenk D, Bock-Henning BS, Bock KW. Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Carcinogenesis 1994; 15:1549-1553.
22. Pantuck EJ, Pantuck CB, Anderson KE, Wattenberg LW, Conney AH, Kappas A. Effect of Brussels sprouts and cabbage on drug conjugation. Clin Pharmacol Ther 1984; 35:161-169.
23. Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 1992; 267:3257-3261.
24. Senafi SB, Clarke DJ, Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-gluronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 1994; 303:233-240.
25. Staack EH, Jeffery EH. Effects of isoflavonoids from soy on rat hepatic drug metabolizing enzymes [abstract]. J Nutr 1994; 19:805S.
26. Ueyama H, Koiwai O, Soeda Y, Sato H, Satoh Y, Ohkubo I, Doida Y. Analysis of the promoter of human bilirubin UDP-glucuronosyltransferase gene (UGT1*1) in relevance to Gilbert's syndrome. Hepatol Res 1997; 9:152-163.
27. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1983; 45:1-7.
28. Yamauchi Y, Yamanouchi I. Transcutaneous bilirubinometry in normal Japanese infants. Acta Paediatr Japonica 1989; 31:65-72.